Pace® Life Sciences to Lead Targeted Drug Delivery Roundtable at Oligo & Peptides HubXchange
Learn more
With experience spanning the development of more than 100 pharmaceutical compounds, Rob brings deep knowledge of dosage form design and development. His hands-on understanding of drug development enables him to guide teams through technical and operational challenges while keeping programs on track as they move from early development toward scale-up.
Rob joined Pace® in 2020 through the acquisition of Emerson Resources where his tenure dates back to 2006.
Rob holds a Master of Science in Pharmaceutical Sciences from Temple University and a Bachelor of Science in Chemical Engineering from Virginia Polytechnic Institute and State University.
Rob holds a Master of Science in Pharmaceutical Sciences from Temple University and a Bachelor of Science in Chemical Engineering from Virginia Polytechnic Institute and State University.
Get in touch
Whether you’re shaping early plans or preparing to scale, our teams are here to help you move forward with clarity and confidence. Start the conversation and we’ll get back to you quickly.
